Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  HYPERTENSION

• Publication date

  1990-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.15.5.459PMID 2185150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Nonpeptide Angiotensin II Receptor Antagonists. IV. EXP6155 and EXP6803

  1989cited by this paper
• Effect of a Monoclonal Antibody to Angiotensin II on Hemodynamic Responses to Noradrenergic Stimulation in Pithed Rats

  1989cited by this paper
• Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.

  1989cited by this paper
• Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307).

  1988cited by this paper
• Non-peptide angiotensin II receptor antagonists. II. Pharmacology of S-8308.

  1988cited by this paper
• Circulating and tissue angiotensin systems.

  1987cited by this paper
• Plasma Angiotensins and Blood Pressure During Converting Enzyme Inhibition

  1987cited by this paper
• Angiotensin-converting enzyme inhibitors.

  1987cited by this paper
• Circulating and Tissue Angiotensin Systems

  1987cited by this paper
• Applied Statistics and the SAS Programming Language

  1986cited by this paper
• Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.

  1986cited by this paper
• Significance of the vascular renin-angiotensin pathway.

  1986cited by this paper
• Conversion of angiotensin-1 to angiotensin-2 by a latent endothelial cell peptidyl dipeptidase that is not angiotensin-converting enzyme.

  1986cited by this paper
• Haemodynamic Responses to Specific Renin-Angiotensin Inhibitors in Hypertension and Congestive Heart Failure

  1984cited by this paper
• Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels

  1983cited by this paper
• Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.

  1982cited by this paper
• Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.

  1981cited by this paper
• Hypotensive Action of Captopril and Saralasin in Intact and Anephric Spontaneously Hypertensive Rats

  1980cited by this paper
• The pharmacologic alteration of renin release.

  1980cited by this paper
• Contribution of the kidneys but not adrenal glands to the acute antihypertensive effects of captopril in spontaneously hypertensive rats.

  1979cited by this paper
• Studies on the mechanism of the hypotensive action of SQ-14225, an angiotensin-converting enzyme inhibitor in anesthetized dogs.

  1979cited by this paper
• Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats.

  1979cited by this paper
• The effect of inhibition of prostaglandin synthesis on tubuloglomerular feedback in the rat kidney

  1979cited by this paper
• Vascular Renin‐like Activity and Blood Pressure Maintenance in the Rat: Studies of the Effect of Changes in Sodium Balance, Hypertension and Nephrectomy

  1979cited by this paper
• Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

  1978cited by this paper
• SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.

  1978cited by this paper
• Role of the Pressor Action of Angiotensin IIin Experimental Hypertension

  1971cited by this paper
• Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

  1969cited by this paper

• JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production.

  2024cites this paper
• Cardiorenai protective effects of sodium-glucose cotransporter 2 inhibition in combination with angiotensin II type 1 receptor blockade in salt-sensitive Dahl rats

  2022cites this paper
• Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility

  2022cites this paper
• Design, synthesis and antihypertensive evaluation of novel codrugs with combined angiotensin type 1 receptor antagonism and neprilysin inhibition.

  2021cites this paper
• Pharmacological Profiles of a Highly Potent and Long-Acting Angiotensin II Receptor Antagonist, Fimasartan, in Rats and Dogs after Oral Administration.

  2017cites this paper
• Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.

  2016influential citation
• Significance of metabolites in bioequivalence: losartan potassium as a case study.

  2014cites this paper
• High-sucrose diets in pregnancy alter angiotensin II-mediated pressor response and microvessel tone via the PKC/Cav1.2 pathway in rat offspring

  2014cites this paper
• A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists

  2013cites this paper
• New insights into the role of aminopeptidases in the treatment for both preeclampsia and preterm labor

  2013cites this paper
• Does chronic pain alter the normal interaction between cardiovascular and pain regulatory systems? Pain modulation in the hypertensive-monoarthritic rat.

  2011cites this paper
• Renin–angiotensin and sympathetic nervous system contribution to high blood pressure in Schlager mice

  2011cites this paper
• Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review.

  2010cites this paper
• The effect of recombinant aminopeptidase A (APA) on hypertension in pregnant spontaneously hypertensive rats (SHRs).

  2009cites this paper
• Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure

  2009cites this paper
• The Effect of Recombinant Aminopeptidase A on Hypertension in Spontaneously Hypertensive Rats: Its Effect in Comparison with Candesartan

  2008cites this paper
• Efeitos cardiovasculares induzidos por antagonistas angiotensinérgicos no bulbo ventrolateral de ratos com hipertensão renovascular.

  2008cites this paper
• An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.

  2007cites this paper
• UvA-DARE ( Digital Academic Repository ) Angiotensin II receptor antagonists and sympathetic neurotransmission

  2007cites this paper
• MICROBIAL HYDROXYLATION AND GLUCURONIDATION OF THE ANGIOTENSIN II (All) RECEPTOR ANTAGONIST

  2006cites this paper
• Regional Hemodynamic Effects of Neutral Endopeptidase Inhibition and Angiotensin (AT1) Receptor Antagonism Alone or in Combination in Conscious Spontaneously Hypertensive Rats

  2006cites this paper
• Effects of Captopril on the Renin Angiotensin System, Oxidative Stress, and Endothelin in Normal and Hypertensive Rats

  2005cites this paper
• Blocking Hypothalamic Al \ Receptors Lowers Blood Pressure in Salt-Sensitive Rats

  2005cites this paper
• Diastereoselective alkylations of β-tetrazolyl propionic acids

  2004cites this paper
• Induced fetal depressor or pressor responses associated with c-fos by intravenous or intracerebroventricular losartan.

  2004cites this paper
• Sympathetic interactions of AT1 receptors

  2004cites this paper
• Antihypertensive Activity of Secoisolariciresinol Diglucoside (SDG) Isolated from Flaxseed: Role of Guanylate Cyclase

  2004cites this paper
• Synthesis of six new 2‐Aryl‐N‐biphenyl benzimidazoles and crystal structure of methyl 4′ [(2‐p‐Chlorophenyl‐1H‐benzimidazole‐1‐yl)‐methyl]biphenyl‐2‐carboxylate

  2004cites this paper
• Is there an answer?

  2004cites this paper
• Role of oxidative stress in angiotensin-induced hypertension.

  2003cites this paper
• Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats.

  2003cites this paper
• AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease.

  2003cites this paper
• Sympatho‐inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar–Kyoto rats

  2003cites this paper
• Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy

  2003cites this paper
• Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.

  2002cites this paper
• Is There an Answer?

  2002cites this paper
• Angiotensin II receptor antagonists and sympathetic neurotransmission

  2002cites this paper
• Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney.

  2001cites this paper
• Angiotensin II is involved in nitric oxide synthase and cyclo‐oxygenase inhibition‐induced leukocyte‐endothelialcell interactions in vivo

  2001cites this paper
• Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats

  2001influential citation
• Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.

  2000cites this paper
• Extrarenal Renin–Angiotensin Systems Are Unable To Maintain Blood Pressure In Sheep

  2000cites this paper
• Angiotensin Antagonists

  2000cites this paper
• Comparative study of the cardiovascular effects of losartan in normal and in water- and salt-depleted sheep.

  2000cites this paper
• In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac β1- or β2-adrenoceptors

  1999cites this paper
• Antihypertensive Mechanisms Underlying a Novel Salt-Sensitive Hypertensive Model Induced by Sensory Denervation

  1999cites this paper
• In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)- or beta(2)-adrenoceptors.

  1999cites this paper
• Pharmacological Characterization of KR‐30988, a Novel Non‐peptide AT1 Receptor Antagonist, in Rat, Rabbit and Dog

  1999influential citation
• Effect of NO Synthesis Inhibition by L-NAME on Systemic and Renal Hemodynamics in Early-and Chronic-Phase 2 K 1 C Hypertensive Rats

  1998cites this paper
• AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.

  1998cites this paper
• Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normotensive rats.

  1998cites this paper
• Hypotensive effect of ZD7155, an angiotensin II receptor antagonist, parallels receptor occupancy in two‐kidney, one‐clip Goldblatt hypertensive rats

  1998cites this paper
• The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats

  1998cites this paper
• Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.

  1998cites this paper
• Discovery of new angiotensin II receptor antagonists. A review of pharmacological studies.

  1998cites this paper
• ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKADE: A NEW DEVELOPMENT IN CARDIOVASCULAR PHARMACOLOGY

  1998cites this paper
• Antihypertensive mechanisms underlying a novel salt-sensitive hypertensive model induced by sensory denervation.

  1998cites this paper
• The discovery and development of angiotensin II antagonists.

  1998cites this paper
• Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR).

  1998cites this paper
• [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].

  1998cites this paper
• EXP3174: The Major Active Metabolite of Losartan

  1997cites this paper
• Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries.

  1997cites this paper
• Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.

  1997cites this paper
• Additive Effects of Captopril and Losartan on Blood Pressure in Mildly Sodium-Depleted Normotensives

  1997cites this paper
• Effect of captopril and losartan on blood pressure and accumulation of LDL and fibrinogen by aortic wall and other tissues in normotensive and hypertensive rats.

  1997cites this paper
• Distribution of Fos-immunoreactivity in rat brain following a dipsogenic dose of captopril and effects of angiotensin receptor blockade.

  1997cites this paper
• Effects of chronic losartan treatment on vascular reactivity in normotensive rats

  1997cites this paper
• Antihypertensive effect of repeatedly administered YM358, an angiotensin AT1-receptor antagonist, in stroke-prone spontaneously hypertensive rats.

  1997cites this paper
• Effect of angiotensin II on corpus cavernosum smooth muscle in relation to nitric oxide environment: in vitro studies in canines

  1997cites this paper
• Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.

  1997cites this paper
• Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist.

  1997cites this paper
• Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.

  1997cites this paper
• Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.

  1997cites this paper
• Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs.

  1997cites this paper
• Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.

  1997cites this paper
• Contribution of nitric oxide to the acute antihypertensive effect of blockers of AT1 angiotensin receptors in spontaneously hypertensive rats.

  1997cites this paper
• Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.

  1997cites this paper
• Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure.

  1996cites this paper
• Simultaneous determination of losartan and active metabolite EXP3174 in rat plasma by HPLC with column switching

  1996cites this paper
• The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.

  1996cites this paper
• Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans.

  1996cites this paper
• Local renin-angiotensin system in sympathetic overactivity of spontaneously hypertensive rats.

  1996cites this paper
• Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.

  1996cites this paper
• Angiotensin II receptor inhibition. A new therapeutic principle.

  1996cites this paper
• Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat

  1996cites this paper
• Angiotensin II receptor blockers. A new class of antihypertensive drugs.

  1996cites this paper
• ANGIOTENSIN II ACTIVATES PRESSOR AND DEPRESSOR SITES OF THE PONTOMEDULLA THAT REACT TO GLUTAMATE

  1996cites this paper
• Biology of angiotensin I1 receptor inhibition with a focus on losartan: a new drug for the treatment of hypertension

  1996cites this paper
• Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat

  1996cites this paper
• Parallel regulation of arginine transport and nitric oxide synthesis by angiotensin II in vascular smooth muscle cells role of protein kinase C

  1996cites this paper
• Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.

  1996cites this paper
• Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.

  1996cites this paper
• Prolonged central effects of quinpirole on cardiovascular regulation.

  1996cites this paper
• Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.

  1996cites this paper
• Angiotensin type 1 receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats.

  1996cites this paper
• Altered age-dependent modulation of tissue renin messenger RNA levels in the spontaneously hypertensive rat

  1996cites this paper
• Effects of chronic blockade of angiotensin II receptor on the maintenance of hypertension and vascular changes in spontaneously hypertensive rats.

  1996cites this paper
• Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II.

  1996cites this paper
• Modulation of G-protein expression by the angiotensin converting enzyme inhibitor captopril in hearts from spontaneously hypertensive rats. Relationship with adenylyl cyclase.

  1996cites this paper
• Alterations of cyclo‐oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat

  1996cites this paper